NORTHWEST BIOTHERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Northwest Biotherapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Northwest Biotherapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 1.3B shares, a 12.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.3B +144M +12.4% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 1.25B +127M +11.3% Aug 6, 2024 10-Q 2024-08-09
Q1 2024 1.2B +122M +11.4% Apr 1, 2024 10-K/A 2024-04-29
Q3 2023 1.15B +101M +9.59% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 1.12B +83.8M +8.08% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 1.07B +113M +11.8% Feb 24, 2023 10-K 2023-02-28
Q3 2022 1.05B +1.05B Nov 8, 2022 10-Q 2022-11-09
Q2 2022 1.04B +165M +18.9% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 960M +118M +14% Feb 25, 2022 10-K/A 2022-06-30
Q3 2021 0 Nov 12, 2021 10-Q 2021-11-15
Q2 2021 872M +162M +22.8% Aug 13, 2021 10-Q 2021-08-16
Q1 2021 842M +193M +29.8% Mar 26, 2021 10-K 2021-03-31
Q4 2020 823M Jan 10, 2021 10-Q 2021-01-15
Q2 2020 710M +132M +22.8% Jun 12, 2020 10-Q 2020-06-24
Q1 2020 649M +112M +20.8% Mar 14, 2020 10-K 2020-03-16
Q3 2019 597M +83.7M +16.3% Nov 11, 2019 10-Q 2019-11-12
Q2 2019 579M +131M +29.1% Aug 8, 2019 10-Q 2019-08-09
Q1 2019 537M +122M +29.5% Apr 1, 2019 10-K 2019-04-02
Q3 2018 513M +218M +73.9% Nov 14, 2018 10-Q 2018-11-16
Q2 2018 448M Aug 13, 2018 10-Q 2018-08-14
Q1 2018 415M +229M +123% Apr 16, 2018 10-K 2018-04-17
Q4 2017 316M Nov 20, 2017 10-Q 2017-11-20
Q3 2017 295M +172M +139% Aug 21, 2017 10-Q 2017-08-21
Q1 2017 186M +84.3M +82.9% Apr 14, 2017 10-K 2017-04-17
Q3 2016 124M +31.3M +33.9% Nov 8, 2016 10-Q 2016-11-10
Q2 2016 114M +35.6M +45.5% Aug 8, 2016 10-Q 2016-08-09
Q1 2016 102M +31.4M +44.7% Mar 10, 2016 10-K 2016-03-16
Q3 2015 92.4M Nov 5, 2015 10-Q 2015-11-09
Q2 2015 78.2M +18.7M +31.4% Aug 7, 2015 10-Q 2015-08-10
Q1 2015 70.3M +16.6M +30.8% Mar 13, 2015 10-K 2015-03-17
Q4 2014 62.2M Nov 18, 2014 10-Q 2014-11-19
Q2 2014 59.5M +25.6M +75.7% Aug 13, 2014 10-Q 2014-08-15
Q1 2014 53.7M +26.6M +98% Mar 28, 2014 10-K 2014-04-01
Q3 2013 38.5M +25.2M +189% Nov 12, 2013 10-Q 2013-11-15
Q2 2013 33.9M -142M -80.7% Aug 8, 2013 10-Q 2013-08-14
Q1 2013 27.1M -131M -82.8% Apr 1, 2013 10-K 2013-04-08
Q3 2012 13.3M -88.4M -86.9% Nov 13, 2012 10-Q 2012-11-14
Q2 2012 176M +81.5M +86.3% Aug 10, 2012 10-Q/A 2012-09-12
Q1 2012 158M Apr 9, 2012 10-K 2012-04-13
Q3 2011 102M Nov 10, 2011 10-Q 2011-11-14
Q2 2011 94.4M Aug 10, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.